Malin Corporation plc (ISE:MLC)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotechnology (Startups)						34.90M	38.00M	41.90M	42.10M
Biotechnology (Startups) Growth						-8.16%	-9.31%	-0.48%	99.16%
Total						34.90M	38.00M	41.90M	42.10M
Total Growth						-8.16%	-9.31%	-0.48%	99.16%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Spain						17.60M	21.00M	23.20M	24.30M
Spain Growth						-16.19%	-9.48%	-4.53%	95.00%
Europe (Excluding Spain)						7.20M	9.00M	13.10M	12.20M
Europe (Excluding Spain) Growth						-20.00%	-31.30%	7.38%	127.87%
Rest of World						10.10M	8.00M	5.60M	5.60M
Rest of World Growth						26.25%	42.86%	0%	68.52%
Total						34.90M	38.00M	41.90M	42.10M
Total Growth						-8.16%	-9.31%	-0.48%	99.16%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 16, 2026

Data Sources Report a data error